Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2018

01-09-2018 | Oculoplastics and Orbit

Clinical features of different orbital manifestations of granulomatosis with polyangiitis

Authors: D. S. Ismailova, J. V. Abramova, P. I. Novikov, Y. O. Grusha

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 9/2018

Login to get access

Abstract

Purpose

The aim of this study was to distinguish different forms of orbital involvement in granulomatosis with polyangiitis (GPA) and to compare their clinical course and outcomes.

Methods

Two hundred twenty-six consecutive patients with GPA were retrospectively studied. All patients fulfilled the classification criteria of American College of Rheumatology; diagnosis of localized GPA was established according to Chapel Hill Consensus. Of those, 74 patients with orbital disease were enrolled into further investigation of different forms of orbital disease.

Results

Overall ocular involvement was diagnosed in 50% (113/226) of patients; in 5.3% (12/226), inflammatory eye disease resulted in permanent visual loss. Most common ophthalmic manifestations were orbital masses, episcleritis/conjunctivitis, and scleritis (74/226, 32/226, and 12/226, respectively). Seventy-four patients with orbital involvement were divided into three groups: those with orbital mass without primary lacrimal gland involvement (1st group, 45 patients), those with lacrimal gland involvement (2nd group, 26 patients), and those with extraocular myositis (3rd group, 3 patients). Symptoms such as orbital pain, decreased vision, double vision, red eye, scleritis, orbital wall destruction, primary gaze strabismus, and ocular motility restriction were significantly more common in the 1st group. Peripheral ulcerative keratitis (PUK) was present in the 1st group only. Patients of the 1st group suffered from visual loss, double vision, primary gaze strabismus, and ocular motility restriction significantly more often. Eleven of them developed visual loss; 5 of them underwent enucleation, whereas in the group of patients with dacryoadenitis, only 1 patient had BCVA less than 0.3.

Conclusions

Three types of orbital disease in GPA were proposed: orbital mass without primary lacrimal gland involvement, dacryoadenitis, and extraocular myositis. Patients with orbital mass without lacrimal gland involvement are characterized with a higher rate of systemic disease, severe clinical course not uncommonly associated with other ophthalmic manifestations (necrotizing scleritis, PUK, orbital walls destruction), relatively unfavorable outcome with high level of morbidity (optic nerve atrophy, anophthalmos, strabismus), and higher rate of recurrences. Dacryoadenitis in GPA showed to be not severe manifestation with favorable prognosis.
Literature
1.
go back to reference Kiseleva TN, Polunina AA (2008) Ophthalmologic manifestations of Wegener’s granulomatosis. Vestn oftalmol 124(1):53–56PubMed Kiseleva TN, Polunina AA (2008) Ophthalmologic manifestations of Wegener’s granulomatosis. Vestn oftalmol 124(1):53–56PubMed
2.
go back to reference Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA (1983) Ocular complications of Wegener’s granulomatosis. Ophthalmology 90(3):279–290CrossRefPubMed Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA (1983) Ocular complications of Wegener’s granulomatosis. Ophthalmology 90(3):279–290CrossRefPubMed
3.
go back to reference Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488–498CrossRefPubMed Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488–498CrossRefPubMed
5.
go back to reference Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, Peel ET, Wood JB (1992) Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1910. Q J Med 83(302):427–438PubMed Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, Peel ET, Wood JB (1992) Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1910. Q J Med 83(302):427–438PubMed
6.
go back to reference Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76–85CrossRefPubMed Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76–85CrossRefPubMed
11.
go back to reference Provenzale JM, Mukherji S, Allen NB, Castillo M, Weber AW (1996) Orbital involvement by Wegener’s granulomatosis: imaging findings. AJR Am J Roentgenol 166(4):929–934CrossRefPubMed Provenzale JM, Mukherji S, Allen NB, Castillo M, Weber AW (1996) Orbital involvement by Wegener’s granulomatosis: imaging findings. AJR Am J Roentgenol 166(4):929–934CrossRefPubMed
12.
go back to reference Boukes RJ, de Vries-Knoppert WA (1985) Lacrimal gland enlargement as one of the ocular manifestations of Wegener’s granulomatosis. Doc Ophthalmol 59(1):21–26CrossRefPubMed Boukes RJ, de Vries-Knoppert WA (1985) Lacrimal gland enlargement as one of the ocular manifestations of Wegener’s granulomatosis. Doc Ophthalmol 59(1):21–26CrossRefPubMed
13.
go back to reference Kiseleva TN, Grusha IO, Polunina AA, Semenkova EN, Abdurakhmanov GA, Nikol'skaia GM (2009) Involvement of lacrimal organs in Wegener’s granulomatosis. Vestn oftalmol 125(4):33–36PubMed Kiseleva TN, Grusha IO, Polunina AA, Semenkova EN, Abdurakhmanov GA, Nikol'skaia GM (2009) Involvement of lacrimal organs in Wegener’s granulomatosis. Vestn oftalmol 125(4):33–36PubMed
14.
go back to reference Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1117CrossRefPubMed Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1117CrossRefPubMed
15.
go back to reference Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192CrossRefPubMed Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192CrossRefPubMed
16.
go back to reference Hellmich B, Flossmann O, Gross WL et al (2007) EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66:605–617CrossRefPubMed Hellmich B, Flossmann O, Gross WL et al (2007) EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66:605–617CrossRefPubMed
17.
go back to reference Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R, European Vasculitis Study Group (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68(3):310–317CrossRefPubMed Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R, European Vasculitis Study Group (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68(3):310–317CrossRefPubMed
18.
go back to reference Devaney KO, Travis WD, Hoffman G et al (1990) Interpretation of head and neck biopsies in Wegener’s granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 14:555–564CrossRefPubMed Devaney KO, Travis WD, Hoffman G et al (1990) Interpretation of head and neck biopsies in Wegener’s granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 14:555–564CrossRefPubMed
19.
go back to reference Holle JU, Gross WL, Holl-Ulrich K et al (2010) Prospective long-term follow-up of patients with localized Wegener’s granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 69:1934–1939CrossRefPubMed Holle JU, Gross WL, Holl-Ulrich K et al (2010) Prospective long-term follow-up of patients with localized Wegener’s granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 69:1934–1939CrossRefPubMed
Metadata
Title
Clinical features of different orbital manifestations of granulomatosis with polyangiitis
Authors
D. S. Ismailova
J. V. Abramova
P. I. Novikov
Y. O. Grusha
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 9/2018
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-018-4014-9

Other articles of this Issue 9/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2018 Go to the issue